Literature DB >> 34550870

A Novel Protective Role for Matrix Metalloproteinase-8 in the Pulmonary Vasculature.

Paul B Dieffenbach1, Christina Mallarino Haeger1, Rakhshinda Rehman1, Alexis M Corcoran1, Anna Maria F Coronata1, Shamsudheen K Vellarikkal2, Izabela Chrobak3, Aaron B Waxman1, Sally H Vitali4, Lynette M Sholl5, Robert F Padera5, David Lagares6, Francesca Polverino1, Caroline A Owen1, Laura E Fredenburgh1.   

Abstract

Rationale: Mechanical signaling through cell-matrix interactions plays a major role in progressive vascular remodeling in pulmonary arterial hypertension (PAH). MMP-8 (matrix metalloproteinase-8) is an interstitial collagenase involved in regulating inflammation and fibrosis of the lung and systemic vasculature, but its role in PAH pathogenesis remains unexplored.
Objectives: To evaluate MMP-8 as a modulator of pathogenic mechanical signaling in PAH.
Methods: MMP-8 levels were measured in plasma from patients with pulmonary hypertension (PH) and controls by ELISA. MMP-8 vascular expression was examined in lung tissue from patients with PAH and rodent models of PH. MMP-8-/- and MMP-8+/+ mice were exposed to normobaric hypoxia or normoxia for 4-8 weeks. PH severity was evaluated by right ventricular systolic pressure, echocardiography, pulmonary artery morphometry, and immunostaining. Proliferation, migration, matrix component expression, and mechanical signaling were assessed in MMP-8-/- and MMP-8+/+ pulmonary artery smooth muscle cells (PASMCs). Measurements and Main
Results: MMP-8 expression was significantly increased in plasma and pulmonary arteries of patients with PH compared with controls and induced in the pulmonary vasculature in rodent PH models. Hypoxia-exposed MMP-8-/- mice had significant mortality, increased right ventricular systolic pressure, severe right ventricular dysfunction, and exaggerated vascular remodeling compared with MMP-8+/+ mice. MMP-8-/- PASMCs demonstrated exaggerated proliferation and migration mediated by altered matrix protein expression, elevated integrin-β3 levels, and induction of FAK (focal adhesion kinase) and downstream YAP (Yes-associated protein)/TAZ (transcriptional coactivator with PDZ-binding motif) activity. Conclusions: MMP-8 is a novel protective factor upregulated in the pulmonary vasculature during PAH pathogenesis. MMP-8 opposes pathologic mechanobiological feedback by altering matrix composition and disrupting integrin-β3/FAK and YAP/TAZ-dependent mechanical signaling in PASMCs.

Entities:  

Keywords:  YAP/TAZ; cellular mechanotransduction; integrin-β3; pulmonary arterial hypertension; pulmonary artery smooth muscle cells

Mesh:

Substances:

Year:  2021        PMID: 34550870      PMCID: PMC8865706          DOI: 10.1164/rccm.202108-1863OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  56 in total

1.  Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2.

Authors:  Paul B Dieffenbach; Christina Mallarino Haeger; Anna Maria F Coronata; Kyoung Moo Choi; Xaralabos Varelas; Daniel J Tschumperlin; Laura E Fredenburgh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-06-22       Impact factor: 5.464

2.  Absence or inhibition of matrix metalloproteinase-8 decreases ventilator-induced lung injury.

Authors:  Guillermo M Albaiceta; Ana Gutierrez-Fernández; Emilio García-Prieto; Xose S Puente; Diego Parra; Aurora Astudillo; Cristina Campestre; Sandra Cabrera; Adrian Gonzalez-Lopez; Antonio Fueyo; Francisco Taboada; Carlos López-Otin
Journal:  Am J Respir Cell Mol Biol       Date:  2009-12-07       Impact factor: 6.914

3.  Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury.

Authors:  Vanessa J Craig; Pablo A Quintero; Susanne E Fyfe; Avignat S Patel; Martin D Knolle; Lester Kobzik; Caroline A Owen
Journal:  J Immunol       Date:  2013-03-13       Impact factor: 5.422

4.  Osteopontin, a Key Mediator Expressed by Senescent Pulmonary Vascular Cells in Pulmonary Hypertension.

Authors:  Mirna Saker; Larissa Lipskaia; Elisabeth Marcos; Shariq Abid; Aurelien Parpaleix; Amal Houssaini; Pierre Validire; Philippe Girard; Hiba Noureddine; Laurent Boyer; Nora Vienney; Valerie Amsellem; Laurent Marguerit; Bernard Maitre; Geneviève Derumeaux; Jean-Luc Dubois-Rande; Claude Jourdan-Lesaux; Marion Delcroix; Rozenn Quarck; Serge Adnot
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-21       Impact factor: 8.311

5.  Distal vessel stiffening is an early and pivotal mechanobiological regulator of vascular remodeling and pulmonary hypertension.

Authors:  Fei Liu; Christina Mallarino Haeger; Paul B Dieffenbach; Delphine Sicard; Izabela Chrobak; Anna Maria F Coronata; Margarita M Suárez Velandia; Sally Vitali; Romain A Colas; Paul C Norris; Aleksandar Marinković; Xiaoli Liu; Jun Ma; Chase D Rose; Seon-Jin Lee; Suzy A A Comhair; Serpil C Erzurum; Jacob D McDonald; Charles N Serhan; Stephen R Walsh; Daniel J Tschumperlin; Laura E Fredenburgh
Journal:  JCI Insight       Date:  2016-06-02

6.  Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension.

Authors:  Adil Anwar; Min Li; Maria G Frid; Binod Kumar; Evgenia V Gerasimovskaya; Suzette R Riddle; B Alexandre McKeon; Roopa Thukaram; Barbara O Meyrick; Mehdi A Fini; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-05-11       Impact factor: 5.464

7.  A functional genetic screen reveals new regulators of β1-integrin activity.

Authors:  Teijo Pellinen; Juha K Rantala; Antti Arjonen; John-Patrick Mpindi; Olli Kallioniemi; Johanna Ivaska
Journal:  J Cell Sci       Date:  2012-02-01       Impact factor: 5.285

8.  Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth.

Authors:  P L Jones; J Crack; M Rabinovitch
Journal:  J Cell Biol       Date:  1997-10-06       Impact factor: 10.539

9.  YAP regulates cell mechanics by controlling focal adhesion assembly.

Authors:  Giorgia Nardone; Jorge Oliver-De La Cruz; Jan Vrbsky; Cecilia Martini; Jan Pribyl; Petr Skládal; Martin Pešl; Guido Caluori; Stefania Pagliari; Fabiana Martino; Zuzana Maceckova; Marian Hajduch; Andres Sanz-Garcia; Nicola Maria Pugno; Gorazd Bernard Stokin; Giancarlo Forte
Journal:  Nat Commun       Date:  2017-05-15       Impact factor: 14.919

10.  Surface-bound matrix metalloproteinase-8 on macrophages: Contributions to macrophage pericellular proteolysis and migration through tissue barriers.

Authors:  Xiaoyun Wang; Duo Zhang; Quynh-Anh Fucci; Clare M Dollery; Caroline A Owen
Journal:  Physiol Rep       Date:  2021-03
View more
  3 in total

Review 1.  Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies.

Authors:  Helen Christou; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-25       Impact factor: 4.733

2.  Leishmania infantum Defective in Lipophosphoglycan Biosynthesis Interferes With Activation of Human Neutrophils.

Authors:  Graziele Quintela-Carvalho; Astrid Madeleine Calero Goicochea; Vanessa Mançur-Santos; Sayonara de Melo Viana; Yasmin da Silva Luz; Beatriz Rocha Simões Dias; Milena Lázaro-Souza; Martha Suarez; Camila Indiani de Oliveira; Elvira M Saraiva; Cláudia I Brodskyn; Patrícia T Veras; Juliana P B de Menezes; Bruno B Andrade; Jonilson Berlink Lima; Albert Descoteaux; Valéria M Borges
Journal:  Front Cell Infect Microbiol       Date:  2022-04-06       Impact factor: 6.073

3.  Matrix Metalloproteinase-8 in Pulmonary Hypertension: The Sheep in the Wolf's Skin?

Authors:  Elena A Goncharova; Tatiana V Kudryashova; Giovanni Maroli; Soni S Pullamsetti
Journal:  Am J Respir Crit Care Med       Date:  2021-12-15       Impact factor: 21.405

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.